The global Oncology Nutrition Deals market size is projected to grow from US$ 1232.6 million in 2022 to US$ 2723.5 million in 2029; it is expected to grow at a CAGR of 12.0% from 2023 to 2029.
The rising incidence of cancer and increasing expenditure on healthcare due to changing lifestyles are expected to drive the growth of this market. Moreover, increasing investment in research and continuous development in technology and treatment are opportunities for players operating in the oncology nutrition market. On the other hand, a lack of knowledge and understanding regarding oncology nutrition can hinder its growth.
Oncology nutrition deals with managing the nutritional intake of patients suffering from cancer to support the treatment and reduce its side effects. The oncology nutrition market can be classified based on the type of cancer, which includes lung cancer, head and neck cancer, stomach cancers, liver cancer, blood cancer, and others; by nutrition, including enteral nutrition and parenteral nutrition.
LPI (LP Information)' newest research report, the “Oncology Nutrition Deals Industry Forecast” looks at past sales and reviews total world Oncology Nutrition Deals sales in 2022, providing a comprehensive analysis by region and market sector of projected Oncology Nutrition Deals sales for 2023 through 2029. With Oncology Nutrition Deals sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oncology Nutrition Deals industry.
This Insight Report provides a comprehensive analysis of the global Oncology Nutrition Deals landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oncology Nutrition Deals portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oncology Nutrition Deals market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oncology Nutrition Deals and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oncology Nutrition Deals.
This report presents a comprehensive overview, market shares, and growth opportunities of Oncology Nutrition Deals market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Enteral Nutrition
Parenteral Nutrition
Segmentation by application
Hospitals
Homecare
Specialty Clinics
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott Laboratories
Ajinomoto Cambrooke
Aceto
American Society for Parenteral and Enteral Nutrition (ASPEN)
Baxter
Danone Nutricia
Fresenius Kabi AG
FMC Corporation
Global Health Products, Inc
Koninklijke DSM N.V.
Mead Johnson & Company, LLC
Nestle Health Science
Smartfish AS
Summary:
Get latest Market Research Reports on Oncology Nutrition Deals. Industry analysis & Market Report on Oncology Nutrition Deals is a syndicated market report, published as Global Oncology Nutrition Deals Market Growth (Status and Outlook) 2023-2029. It is complete Research Study and Industry Analysis of Oncology Nutrition Deals market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.